Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India

Author:

Kshatri Jaya Singh, ,Bhattacharya Debdutta,Kanungo Srikanta,Giri Sidhartha,Palo Subrata Kumar,Parai DebaprasadORCID,Turuk Jyotirmayee,Mansingh Asit,Choudhary Hari Ram,Pattnaik Matrujyoti,Dash Girish Chandra,Mohanty Prasantajyoti,Mishra Niranjan,Satapathy Durga Madhab,Sahoo Sanjaya Kumar,Pati Sanghamitra

Abstract

AbstractThis was a population based cross-sectional study carried out to estimate and compare the seroprevalence, hidden prevalence and determine the demographic risk factors associated with SARS-CoV-2 infection among adults in the three largest cities of Odisha, India, and ascertain the association with the progression of the epidemic. The survey carried out in August 2020 in the three largest cities of the state of Odisha, India. Blood samples were collected from the residents using random sampling methods and tested for anti- SARS CoV-2 antibodies using an automated CLIA platform. A total of 4146 participants from the 3 cities of Bhubaneswar (BBS), Berhampur (BAM) and Rourkela (RKL) participated. The female to male participation ratio was 5.9:10 across the three cities. The gender weighted seroprevalence across the three cities was 20.78% (95% CI 19.56–22.05%). While females reported a higher seroprevalence (22.8%) as compared to males (18.8%), there was no significant difference in seroprevalence across age groups. A majority of the seropositive participants were asymptomatic (90.49%). The case to infection ratio on the date of serosurvey was 1:6.6 in BBS, 1:61 in BAM and 1:29.8 in RKL. The study found a high seroprevalence against COVID-19 in urban Odisha as well as high numbers of asymptomatic infections. The epidemic curves had a correlation with the seroprevalence.

Funder

Odisha Department of Health and Family welfare, Odisha Mining Corporation

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference31 articles.

1. WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard.

2. Govt. of India, MoHFW, Dashboard.

3. COVID-19: Odisha State Dashboard.

4. World Health Organization (WHO). Seroepidemiological investigation protocol for coronavirus 2019 ( COVID-19 ) infection. (2020).

5. CDC. Overview of Testing for SARS-CoV-2 | CDC. Centers for Disease Control and Prevention (2020).

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3